FR2828487B1 - Nouveaux composes derives d'acides gras, preparation et utilisations - Google Patents

Nouveaux composes derives d'acides gras, preparation et utilisations

Info

Publication number
FR2828487B1
FR2828487B1 FR0110645A FR0110645A FR2828487B1 FR 2828487 B1 FR2828487 B1 FR 2828487B1 FR 0110645 A FR0110645 A FR 0110645A FR 0110645 A FR0110645 A FR 0110645A FR 2828487 B1 FR2828487 B1 FR 2828487B1
Authority
FR
France
Prior art keywords
preparation
fatty acids
novel compounds
compounds derived
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0110645A
Other languages
English (en)
French (fr)
Other versions
FR2828487A1 (fr
Inventor
Fruchart Jamila Najib
Bertrand Karine Caumont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0110645A priority Critical patent/FR2828487B1/fr
Application filed by Genfit SA filed Critical Genfit SA
Priority to AT02779622T priority patent/ATE373638T1/de
Priority to DE60222596T priority patent/DE60222596T2/de
Priority to US10/484,350 priority patent/US7375135B2/en
Priority to AU2002342968A priority patent/AU2002342968B2/en
Priority to PCT/FR2002/002831 priority patent/WO2003014073A1/fr
Priority to EP02779622A priority patent/EP1673338B1/fr
Priority to JP2003519023A priority patent/JP2004537595A/ja
Priority to PT02779622T priority patent/PT1673338E/pt
Priority to ES02779622T priority patent/ES2292824T3/es
Priority to SI200230624T priority patent/SI1673338T1/sl
Priority to DK02779622T priority patent/DK1673338T3/da
Priority to CA002456288A priority patent/CA2456288A1/fr
Publication of FR2828487A1 publication Critical patent/FR2828487A1/fr
Application granted granted Critical
Publication of FR2828487B1 publication Critical patent/FR2828487B1/fr
Priority to CY20071101482T priority patent/CY1107806T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
FR0110645A 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations Expired - Fee Related FR2828487B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0110645A FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations
SI200230624T SI1673338T1 (sl) 2001-08-09 2002-08-08 Spojine maščobne kisline, priprava in njihova uporaba
US10/484,350 US7375135B2 (en) 2001-08-09 2002-08-08 Fatty acid derivatives; preparation and uses thereof
AU2002342968A AU2002342968B2 (en) 2001-08-09 2002-08-08 Fatty acid compounds, preparation and uses thereof
PCT/FR2002/002831 WO2003014073A1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
EP02779622A EP1673338B1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
JP2003519023A JP2004537595A (ja) 2001-08-09 2002-08-08 脂肪酸誘導体、その製造法及び使用
PT02779622T PT1673338E (pt) 2001-08-09 2002-08-08 Compostos derivados de ácidos gordos, preparação e utilizações
AT02779622T ATE373638T1 (de) 2001-08-09 2002-08-08 Fettsäureverbindungen und deren herstellung und verwendungen
DE60222596T DE60222596T2 (de) 2001-08-09 2002-08-08 Fettsäureverbindungen und deren herstellung und verwendungen
DK02779622T DK1673338T3 (da) 2001-08-09 2002-08-08 Forbindelser afledt af fedtsyrer, fremstilling og anvendelse
CA002456288A CA2456288A1 (fr) 2001-08-09 2002-08-08 Composes derives d'acides gras preparation et utilisations
ES02779622T ES2292824T3 (es) 2001-08-09 2002-08-08 Compuestos derivados de acidos grasos, preparacion y utilizaciones.
CY20071101482T CY1107806T1 (el) 2001-08-09 2007-11-16 Ενωσεις παραγωγα λιπαρων οξεων, παρασκευη και χρησεις τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0110645A FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations

Publications (2)

Publication Number Publication Date
FR2828487A1 FR2828487A1 (fr) 2003-02-14
FR2828487B1 true FR2828487B1 (fr) 2005-05-27

Family

ID=8866413

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0110645A Expired - Fee Related FR2828487B1 (fr) 2001-08-09 2001-08-09 Nouveaux composes derives d'acides gras, preparation et utilisations

Country Status (13)

Country Link
US (1) US7375135B2 (enExample)
EP (1) EP1673338B1 (enExample)
JP (1) JP2004537595A (enExample)
AT (1) ATE373638T1 (enExample)
AU (1) AU2002342968B2 (enExample)
CA (1) CA2456288A1 (enExample)
CY (1) CY1107806T1 (enExample)
DE (1) DE60222596T2 (enExample)
DK (1) DK1673338T3 (enExample)
ES (1) ES2292824T3 (enExample)
FR (1) FR2828487B1 (enExample)
PT (1) PT1673338E (enExample)
WO (1) WO2003014073A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) * 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
FR2850870B1 (fr) * 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2853834B1 (fr) * 2003-04-17 2008-08-15 Vincience Composition cosmetique ou pharmaceutique comprenant l'association d'au moins un diacyglycerol et d'au moins un alcool gras
FR2858216B1 (fr) * 2003-07-31 2008-04-04 Oreal Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
RU2394598C2 (ru) * 2004-07-19 2010-07-20 Тиа Медика Ас Композиция, содержащая белковый материал и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
AU2005264782B2 (en) * 2004-07-19 2010-12-16 Thia Medica As Composition comprising protein material and non-oxidizable fatty acid entities
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
DE102007051338A1 (de) * 2007-10-26 2009-04-30 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
US8741966B2 (en) 2007-11-09 2014-06-03 Pronova Biopharma Norge As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
JP5843755B2 (ja) 2009-05-08 2016-01-13 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
EP2445494A4 (en) * 2009-06-24 2012-12-12 Univ Koebenhavn TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
NZ610705A (en) 2010-11-05 2014-10-31 Pronova Biopharma Norge As Methods of treatment using lipid compounds
AU2014222389B2 (en) 2013-02-28 2018-11-29 Pronova Biopharma Norge As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
US20180104201A1 (en) 2015-04-28 2018-04-19 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and or treating non alcoholic steatohepatitis
EP3298024B1 (en) 2015-05-20 2020-04-01 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
EP3349589B1 (en) 2015-09-16 2022-12-14 Apeel Technology, Inc. Method for forming a protective coating by applying fatty acid glyceride compounds to a surface
FR3044556B1 (fr) 2015-12-08 2019-10-18 Pierre Fabre Dermo-Cosmetique Utilisation de diglyceride 1,3 dans une composition topique pour lutter contre la fragilisation de la barriere cutanee
ES2797697T3 (es) 2015-12-10 2020-12-03 Apeel Tech Inc Proceso para despolimerizar cutina
WO2017132281A1 (en) 2016-01-26 2017-08-03 Apeel Technology, Inc. Method for preparing and preserving sanitized products
JP7194678B2 (ja) 2016-11-17 2022-12-22 アピール テクノロジー，インコーポレイテッド 植物抽出物から形成される組成物及びその調製方法
AU2018354090B2 (en) 2017-10-23 2024-10-24 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
PT3720431T (pt) 2017-12-06 2024-12-05 Basf As Derivados de ácidos gordos para o tratamento da esteato-hepatite não alcoólica
WO2019222254A1 (en) * 2018-05-16 2019-11-21 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to aging
WO2019226572A1 (en) 2018-05-23 2019-11-28 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
EP3908374A4 (en) 2019-01-09 2022-12-28 Epitracker, Inc. COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
EP3934639A4 (en) 2019-03-04 2023-01-11 Epitracker, Inc. FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE DISORDERS, BEHAVIORAL DISORDERS AND CHRONIC PAIN
JP7578707B2 (ja) 2020-03-04 2024-11-06 アピール テクノロジー，インコーポレイテッド 被覆された農産物及び対応する方法
MX2023004343A (es) 2020-10-30 2023-05-08 Apeel Tech Inc Composiciones y metodos de preparacion de las mismas.
CN118159138A (zh) 2021-09-08 2024-06-07 阿比尔技术公司 用于保护性涂层的化合物和制剂
WO2023080939A1 (en) 2021-11-03 2023-05-11 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
US12133863B1 (en) * 2023-06-07 2024-11-05 King Saud University Green synthesis of silver nanoparticles encapsulated in a nanostructured lipid carrier

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010154A (en) * 1933-06-27 1935-08-06 Herbert S Kreighbaum Ether acid ester of polyhydric alcohols
GB1271179A (en) * 1969-06-11 1972-04-19 Mitsubishi Petrochemical Co Polyolefin resin composition
JPS5738616B2 (enExample) * 1974-06-19 1982-08-17
US4134770A (en) * 1976-09-22 1979-01-16 Mitsubishi Paper Mills, Ltd. Gelatin-containing photographic layer incorporated with hardener
IL59407A (en) * 1979-03-06 1983-12-30 Sanofi Sa Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them
JPS5782573A (en) * 1980-11-05 1982-05-24 Matsumoto Yushi Seiyaku Kk Smoothening treatment agent for thermoplastic synthetic fiber
GB8813012D0 (en) 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
WO1991003542A1 (fr) * 1989-09-11 1991-03-21 Kao Corporation Composition de blanchiment
NO952796D0 (no) 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
JP4349744B2 (ja) 1997-08-29 2009-10-21 ザ・ジョーンズ・ホプキンス・ユニバーシティ 抗菌化合物
JP2000169443A (ja) 1998-10-02 2000-06-20 Sankyo Co Ltd ジチオ―ル誘導体
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
FR2850650B1 (fr) 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850870B1 (fr) 2003-02-12 2006-07-28 Genfit S A Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
FR2850869B1 (fr) 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
FR2850969B1 (fr) 2003-02-12 2005-03-25 Genfit S A Aminopropanediols acyles et analogues et leurs utilisations therapeutiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261705C1 (ru) * 2004-01-29 2005-10-10 Медведев Илья Николаевич Способ лечения тромбоцитопатии при метаболическом синдроме

Also Published As

Publication number Publication date
PT1673338E (pt) 2007-12-12
WO2003014073A1 (fr) 2003-02-20
AU2002342968B2 (en) 2008-05-15
CY1107806T1 (el) 2013-06-19
EP1673338B1 (fr) 2007-09-19
CA2456288A1 (fr) 2003-02-20
DK1673338T3 (da) 2008-01-14
US7375135B2 (en) 2008-05-20
FR2828487A1 (fr) 2003-02-14
US20040192908A1 (en) 2004-09-30
EP1673338A1 (fr) 2006-06-28
DE60222596D1 (de) 2007-10-31
JP2004537595A (ja) 2004-12-16
ATE373638T1 (de) 2007-10-15
ES2292824T3 (es) 2008-03-16
DE60222596T2 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
DK1673338T3 (da) Forbindelser afledt af fedtsyrer, fremstilling og anvendelse
ATE113281T1 (de) Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
FI813033L (fi) Substituerade acylderivat av 1,2,3,4-tetrahydroisokinolin-3-karboxylsyror
DE60231555D1 (de) Verbesserte synthese von polyanhydriden
ATE328965T1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
AR013608A1 (es) Derivados de 3,4-diariloxazolona, procedimiento para su preparacion, y composicion farmaceutica que los comprende.
KR900000351A (ko) 1-아릴-나프토일아민 및 그의 제조방법
YU5199A (sh) Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija
ATE229000T1 (de) Verfahren zur herstellung von alpha-aminoketonen
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
ATE82861T1 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
GR910100202A (el) Μέθοδος δια την παρασκευή 2,2-διμεθυλ-5(2,5 διμεθυλοφαινοξυ)-πεντανοϊκού οξέος, ενδιάμεσων ουσιών και μέθοδος δια την παρασκευή των ενδιάμεσων ουσιών.
DK0643055T3 (da) Fremgangsmåde til fremstilling af 5-amino-2,2-dialkyl-1,3-dioxaner
ATE165824T1 (de) Verfahren zur herstellung von 2-perfluoroalkyl-3- oxazolin-5-one
ATE277051T1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
KR870004038A (ko) 제초제 화합물의 제조방법
ATE434611T1 (de) Verfahren zur herstellung von estern der amicsäure
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
DE69619402D1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
DE3580587D1 (de) Ester der 0(2,6-dichlorphenylamino)phenylessigsaeure und ein verfahren zur deren herstellung.
DE69618096D1 (de) Neue carbonsäure-derivate, verfahren zur herstellung und diese verbindungen enthaltende insektizide
JPS5578033A (en) Stabilized synthetic resin composition

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100430